Sudip Bandyopadhyay advises caution in pharma due to US tariff uncertainties, recommending domestic-focused companies like Mankind Pharma for growth. He also anticipates a strong Q3 for value retailers, including V-Mart, driven by rising incomes and festive demand. Overall, domestic sectors offer safer growth amidst global volatility.
